1. Home
  2. Labeler Index
  3. Aphena Pharma Solutions - Tennessee, Llc
  4. 71610-948
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Label - 71610 0948 30
  2. Aphena - Aphena
  3. Chemical Structure - pregabalin 01
  4. Figure 1 - pregabalin 02
  5. Figure 2 - pregabalin 03
  6. Figure 3 - pregabalin 04
  7. Figure 4 - pregabalin 05
  8. Figure 5 - pregabalin 06
  9. Figure 6 - pregabalin 07
  10. Figure 7 - pregabalin 08
  11. Figure 9 - pregabalin 09
  12. Figure 10 - pregabalin 10
  13. Figure 11 - pregabalin 11
  14. Figure 12 - pregabalin 12

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 71610-948 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 71610 0948 30

Label - 71610 0948 30

Aphena - Aphena

Aphena - Aphena

Chemical Structure - pregabalin 01

Chemical Structure - pregabalin 01

Figure 1 - pregabalin 02

Figure 1 - pregabalin 02

Figure 2 - pregabalin 03

Figure 2 - pregabalin 03

This text provides information about the percent of patients who improved while taking Pregabalin 100 mg. It shows the time intervals and pain improvement percentages from the baseline.*

Figure 3 - pregabalin 04

Figure 3 - pregabalin 04

This data shows the percentage of patients whose pain improved when taking different doses of Pregabalin (300mg, 150mg, 75mg) two times a day compared to a placebo. The chart ranges from 0% to 100% for improvement in pain from the baseline.*

Figure 4 - pregabalin 05

Figure 4 - pregabalin 05

This text provides information on the percent of patients improved with different treatments, specifically Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and Placebo. The data shows the percent of improvement in pain from baseline, although specific numeric values are unclear due to errors.*

Figure 5 - pregabalin 06

Figure 5 - pregabalin 06

This information shows the percent of patients improved with different treatments: Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and Placebo. The graph displays the percent improvement in pain from baseline over a range of values from 20 to 100.*

Figure 6 - pregabalin 07

Figure 6 - pregabalin 07

Figure 7 - pregabalin 08

Figure 7 - pregabalin 08

Seizure Reduction data for different studies under different dosing frequencies (BID and TID) are presented. The median percentage change from baseline in seizures is provided for each study. The studies mentioned are labeled as E1, E2, and E3. The data appears to involve a drug called Pacabo, with the doses possibly indicated in mg/day.*

Figure 9 - pregabalin 09

Figure 9 - pregabalin 09

Figure 10 - pregabalin 10

Figure 10 - pregabalin 10

Figure 11 - pregabalin 11

Figure 11 - pregabalin 11

Figure 12 - pregabalin 12

Figure 12 - pregabalin 12

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.